A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele*
暂无分享,去创建一个
[1] R. Giscombe,et al. Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis. , 2002, The Journal of rheumatology.
[2] Nitin J. Karandikar,et al. The role of CTLA‐4 in induction and maintenance of peripheral T cell tolerance , 2002, European journal of immunology.
[3] P. Rieckmann,et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation , 2002, Immunogenetics.
[4] T. Yanagawa,et al. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves’ disease , 2002, Journal of endocrinological investigation.
[5] S. Pearce,et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. , 2002, Rheumatology.
[6] D. Curtis,et al. CTLA-4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families , 2002, Journal of medical genetics.
[7] J. Franklyn,et al. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. , 2002, Thyroid : official journal of the American Thyroid Association.
[8] J. Partanen,et al. Technical Note: Linkage Disequilibrium and Disease-Associated CTLA4 Gene Polymorphisms , 2001, The Journal of Immunology.
[9] X. Chen,et al. Signal Peptidase and Oligosaccharyltransferase Interact in a Sequential and Dependent Manner within the Endoplasmic Reticulum* , 2001, The Journal of Biological Chemistry.
[10] M. Fisfalen,et al. CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ Disease1 , 2000, The Journal of Immunology.
[11] J. Dubuisson,et al. Glycosylation of the Hepatitis C Virus Envelope Protein E1 Is Dependent on the Presence of a Downstream Sequence on the Viral Polyprotein* , 2000, The Journal of Biological Chemistry.
[12] J. Bluestone,et al. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.
[13] J. Rotter,et al. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. , 2000, Diabetes.
[14] A Helenius,et al. Setting the standards: quality control in the secretory pathway. , 1999, Science.
[15] T. Mak,et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. , 1999, Journal of immunology.
[16] P. Bousso,et al. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Spiess,et al. Mechanism of Endoplasmic Reticulum Retention of Mutant Vasopressin Precursor Caused by a Signal Peptide Truncation Associated with Diabetes Insipidus* , 1999, The Journal of Biological Chemistry.
[18] M. McCarthy,et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. , 1999, Human molecular genetics.
[19] J. Bluestone,et al. Molecular basis of T cell inactivation by CTLA-4. , 1998, Science.
[20] Watson,et al. A cytotoxic T lymphocyte antigen‐4 (CTLA‐4) gene polymorphism is associated with autoimmune Addison's disease in English patients , 1998, Clinical endocrinology.
[21] J. Bach,et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease , 1998, Gut.
[22] D. Ogrydziak,et al. Another Factor Besides Hydrophobicity Can Affect Signal Peptide Interaction with Signal Recognition Particle* , 1998, The Journal of Biological Chemistry.
[23] J. Bluestone,et al. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. , 1998, Journal of immunology.
[24] C. Benoist,et al. Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.
[25] N. Kuzuya,et al. Association of CTLA-4 Gene A-G Polymorphism (IDDM12 Locus) With Acute-Onset and Insulin-Depleted IDDM as Well as Autoimmune Thyroid Disease (Graves' Disease and Hashimoto's Thyroiditis) in the Japanese Population , 1998, Diabetes.
[26] Richard Hughey,et al. Hidden Markov models for detecting remote protein homologies , 1998, Bioinform..
[27] T. Sullivan,et al. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. , 1997, Immunity.
[28] T. Saruta,et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. , 1997, Thyroid : official journal of the American Thyroid Association.
[29] F. Schuit,et al. CTLA‐4 gene polymorphism confers susceptibility to insulin‐dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers , 1997, Clinical and experimental immunology.
[30] J. Rotter,et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. , 1997, Human molecular genetics.
[31] K. Constantine,et al. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 , 1997, Nature Structural Biology.
[32] K. Kotsa,et al. A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism , 1997, Clinical endocrinology.
[33] T. Strom,et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.
[34] J. Allison,et al. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.
[35] S. Brunak,et al. SHORT COMMUNICATION Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites , 1997 .
[36] D. Y. Thomas,et al. Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Todd,et al. Panning for gold: genome-wide scanning for linkage in type 1 diabetes. , 1996, Human molecular genetics.
[38] C. June,et al. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. , 1996, Journal of immunology.
[39] Nitin J. Karandikar,et al. CTLA-4: a negative regulator of autoimmune disease , 1996, The Journal of experimental medicine.
[40] J. Todd,et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. , 1996, Human molecular genetics.
[41] J. Winther,et al. Competition between folding and glycosylation in the endoplasmic reticulum. , 1996, The EMBO journal.
[42] K. Bennett,et al. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.
[43] J. Allison,et al. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells , 1996, The Journal of experimental medicine.
[44] L. Kasturi,et al. The Amino Acid at the X Position of an Asn-X-Ser Sequon Is an Important Determinant of N-Linked Core-glycosylation Efficiency (*) , 1996, The Journal of Biological Chemistry.
[45] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[46] J. Bluestone,et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.
[47] Peter S. Linsley,et al. Cytotoxic T Lymphocyte-associated Molecule-4, a High Avidity Receptor for CD80 and CD86, Contains an Intracellular Localization Motif in Its Cytoplasmic Tail (*) , 1995, The Journal of Biological Chemistry.
[48] James R. Eshleman,et al. The Hydroxy Amino Acid in an Asn-X-Ser/Thr Sequon Can Influence N-Linked Core Glycosylation Efficiency and the Level of Expression of a Cell Surface Glycoprotein (*) , 1995, The Journal of Biological Chemistry.
[49] Henry M. Kronenberg,et al. Inefficient Membrane Targeting, Translocation, and Proteolytic Processing by Signal Peptidase of a Mutant Preproparathyroid Hormone Protein (*) , 1995, The Journal of Biological Chemistry.
[50] P. Linsley,et al. CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.
[51] M. Ito,et al. Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus. , 1993, The Journal of clinical investigation.
[52] M. Racchi,et al. Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. , 1993, The Journal of biological chemistry.
[53] Ylva Gavel,et al. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering , 1990, Protein engineering.
[54] G. Deléage,et al. A computerized version of the Chou and Fasman method for predicting the secondary structure of proteins. , 1987, Analytical biochemistry.
[55] Thomas A. Kunkel,et al. Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[56] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.